Clinical Trials Logo

Filter by:
NCT ID: NCT03894176 Completed - STEMI Clinical Trials

Association of Plasma PTX3 Concentration and Outcomes of STEMI

Start date: January 1, 2018
Phase:
Study type: Observational

335 of patients with STEMI treated by primary PCI were assayed for PTX3 measurement by ELISA method. The angiographic and clinical outcomes were evaluated according to the PTX3 concentration.

NCT ID: NCT03893513 Completed - Clinical trials for Hemodynamic Monitoring

Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients

Start date: March 12, 2019
Phase:
Study type: Observational

Hemodynamics monitoring using non-invasive transthoracic electrical bioimpedance ICON are compatible with standard invasive monitoring using pulse contour analysis EV1000

NCT ID: NCT03891589 Completed - Nutritional Status Clinical Trials

Optimized Complementary Feeding With or Without Home Fortification Prevents Decrease of Micronutrient and Growth

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Malnourished among under-five children characterized by growth faltering is a public health concern in Indonesia. It requires serious action from the governments because of the prevalence of underweight, stunting, and wasting are increasing. These impacts are irreversible resulting in the low quality of future human resources. Several studies showed that growth faltering among under-five children starts at age six months when the amount of breastmilk reduced, complementary feeding initiated, and risk for infection is increased. A rapid growth phase also causes growth faltering at age 6-24 months. The inadequate amount and low quality of food during this period can also lead to reducing nutritional status. The Indonesian Government released a national policy in 2013 to address undernutrition among under-five children called the Indonesia President Regulation No. 42/2013 regarding national movements on the acceleration of nutritional programs to address micronutrients deficiency among under-five children by providing micronutrient powder (MNP) (called Taburia) for children aged 6 - 59 months. Our literature review documented that there is no study ever conducted to evaluate the effectiveness of MNP (Taburia) in improving the weight and height of the children. Moreover, behavioral modification interventions to promote food diversification to improve nutrient intake and to prevent micronutrient deficiency are also never conducted. Based on the rationale and study concept, the following hypotheses are 1). Promotion of optimized complementary feeding along with or without multi-micronutrient powder or MNP (namely taburia) can prevent reductions in nutrient intake and density; serum ferritin and zinc levels; and anthropometric z-score index compared to controls, and 2) provision of MNP can prevent reductions in nutrient intake and density; serum ferritin and zinc levels; and anthropometric z-score index compared to controls.

NCT ID: NCT03889470 Recruiting - Clinical trials for Radial Artery Injury

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

NORAS
Start date: March 31, 2018
Phase: Phase 4
Study type: Interventional

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

NCT ID: NCT03885973 Completed - Clinical trials for Constipation - Functional

Lactobacillus Plantarum IS 10560 Supplementation in Women With Functional Constipation

Start date: July 28, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

In this study, the investigators measured the SCFA (Butyrate, Acetate and Propionate) as a Biomarker improvement symptom and quality of life women with functional constipation after supplementation of commensal bacterial fermented milk Lactobacillus plantarum (isolated from indigenous probiotics from Dadih, West Sumatra) for 21 days

NCT ID: NCT03879980 Completed - Postoperative Pain Clinical Trials

Effect of Quadratus Lumborum Block on Perioperative Analgesia and Inflammatory Responses in Laparoscopic Nephrectomy

Start date: March 18, 2019
Phase: N/A
Study type: Interventional

Quadratus lumborum (QL) block can reduce intraoperative opioid consumption, decrease inflammation responses of IL-6, and reduce acute pain intensity in comparison with non-receiving QL block as the control group.

NCT ID: NCT03870204 Completed - Clinical trials for Aged =2 Years in Schistosomiasis Affected Areas

Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum

SchisCCA
Start date: September 4, 2019
Phase:
Study type: Observational

This is a longitudinal cohort study that will be coordinated with the 2019 schistosomiasis stool survey in Napu. The study will use the stool survey results as entry criteria to identify subjects to become the index cases. Contact investigation will be conducted to the index cases during home visit (Visit 1). The index cases and their contacts meeting the study's eligibility criteria will be recruited. For Visit 1, they will be tested for schistosomiasis by on the spot POC-CCA, stool samples will be tested for KK at Donggala R&D Center Laboratory and urinary tract infection (UTI) by urine dipsticks, stool samples will be tested for schistosomiasis and soil transmitted helminths (STH) by KK at Donggala R&D Center Laboratory and by molecular assay (Taqman qPCR) at the INA-RESPOND Reference Laboratory, while dried blood spots samples will be tested for schistosome antibodies by ELISA at the INA-RESPOND Reference Laboratory. The study KK and/or POC-CCA will be used to determine their schistosomiasis status. Those with positive schistosomiasis status by KK and/or POC-CCA will continue follow up to Visit 2 and 3.

NCT ID: NCT03851120 Active, not recruiting - Health Behavior Clinical Trials

Brain Probiotic and LC-PUFA Intervention for Optimum Early Life

BRAVE
Start date: October 31, 2019
Phase: Phase 2
Study type: Interventional

Probiotics is suggested to play several roles in promoting health, including alleviating disease symptoms, protection against atopic disease, and modulating the immune system by improving the beneficial gut microbiota colonization. The discovery of the gut microbiota-brain axis suggested that there is a reciprocal influence between the brain and the gut through a constant communication. This bi-directional axis enables signals to be transferred from brain to influence sensory, motor, and secretory modalities of the GI tract, also permits signal from the gut to influence brain function. The establishment of intestinal microbiota during early neurodevelopmental period suggests the colonization and maturation of gut microbiota may influence brain development. Several studies have shown there is an association between shifts in the gut microbiota composition in children with neurodevelopmental disorders. This study aims to investigate how maternal probiotic + LC-PUFA supported with government program supplements, healthy eating, and psychosocial stimulation could affect fetal brain development and later child brain functions and cognitive development. Intervention would be delivered to pregnant women for 9 months, starting at the end of second trimester of gestational period.

NCT ID: NCT03834454 Completed - Clinical trials for Postoperative Complications

Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population

Start date: October 1, 2013
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy of hyperbaric 5 mg bupivacaine + fentanyl 25 mcg versus hyperbaric 7.5 mg bupivacaine + fentanyl 25 mcg to lower incidence of hypotension

NCT ID: NCT03829358 Completed - Clinical trials for Constipation - Functional

The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation

Start date: February 24, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study aimed to investigate the relationship between administration of probiotics and improvement in quality of life in women with functional constipation.